AzTrials
AzTrials

Radial ArteryNCT04303923

Reference Diameter and Characteristics of Distal Radial Artery by Ultrasonographic Assessement in Korean Patients

An observational study of Radial Artery, run by Wonju Severance Christian Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Radial access is recommended as the standard approach for coronary angiography (CAG) and percutaneous coronary intervention (PCI) based on the evidence in which RA reduced mortality and bleeding events compared with femoral access. Read more about this study

Who is it for?
Ages 20 years and olderHealthy volunteers can take part
Conditions the study is for
Radial Artery
What is being tested?
Ultrasonography
Type of treatment
Surgery or procedure
How many people
1,162 participants
Where
1 siteSouth Korea
Study dates
7 Jul 2017to 29 Feb 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients planned to perform transthoracic echocardiography with arterial ultrasonography were consecutively enrolled in a single center.

Who may be able to join

  • Patients planned to perform transthoracic echocardiography with arterial ultrasonography

Who cannot join

  • Age under 20-year
  • Poor image quality
  • repeated measurement

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Wonju Severance Christian Hospital

    Wŏnju, Gangwon-do, 26426

Other trials in South Korea

About this study

Radial access is recommended as the standard approach for coronary angiography (CAG) and percutaneous coronary intervention (PCI) based on the evidence in which RA reduced mortality and bleeding events compared with femoral access. Recently, the use of distal radial artery (DRA) is rapidly increasing in accordance with the publication of several studies that have shown easy hemostasis, reduced bleeding complications and low arterial occlusion rate via distal radial approach. However, the diameter of DRA is relatively smaller than radial artery (RA) which can limit the widespread use of this access route. Regarding the size discrepancy, there is a lack of evidence to guide which patients are acceptable or not for CAG and PCI. Therefore, the main purpose of this study was to provide the reference diameter of DRA using ultrasonography in Korean patients. The clinical predictors for small DRA also were evaluated.

Read the detailed description

Radial access is recommended as the standard approach for coronary angiography (CAG) and percutaneous coronary intervention (PCI) based on the evidence in which RA reduced mortality and bleeding events compared with femoral access. Recently, the use of distal radial artery (DRA) is rapidly increasing in accordance with the publication of several studies that have shown easy hemostasis, reduced bleeding complications and low arterial occlusion rate via distal radial approach. However, the diameter of DRA is relatively smaller than radial artery (RA) which can limit the widespread use of this access route. Regarding the size discrepancy, there is a lack of evidence to guide which patients are acceptable or not for CAG and PCI. Therefore, the main purpose of this study was to provide the reference diameter of DRA using ultrasonography in Korean patients. The clinical predictors for small DRA also were evaluated.

Assessment of arterial diameter by ultasonography Patients were lying on the bed with relaxation in an quiet room. The outer diameters of both DRA and RA were assessed by a perpendicular angle using a linear ultrasound probe (3-4-10.8 MHz) and the average values were recorded. The diameter of RA was measured from 2-3 cm above wrist crease. Anatomical landmark for the measurement of DRA was the bony surface area just distal space from extensor pollicis longus tendon in which the DRA was best palpable then runs down between the first metacarpal and second metacarpal bone (just out of anatomical snuffbox area)

Conditions
Radial Artery
Being tested
Ultrasonography
Keywords
anatomical snuffbox, distal radial artery, radial artery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • UltrasonographyProcedure or surgery

    The diameters of both the radial artery and the distal radial artery were measured by ultrasonography.

Study groups in NCT04303923
Study groupRoleWhat they receive
Male groupMale patients who performed transthoracic echocardiography with arterial ultrasonography
Receives: Procedure: Ultrasonography
Female groupFemale patients who performed transthoracic echocardiography with arterial ultrasonography
Receives: Procedure: Ultrasonography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The diameter of distal radial artery

    Mean diameter of distal radial artery on both left and right hand

    Measured: Through ultrasonographic evaluation (within 1 hour)

Secondary outcomes (4)
  1. The diameter of radial artery

    Mean diameter of radial artery on both left and right hand

    Measured: Through ultrasonographic evaluation (within 1 hour)

  2. Arterial diameter index

    Diameter of measure artery divided by body surface area

    Measured: Through ultrasonographic evaluation (within 1 hour)

  3. Proportion of small distal radial artery

    Proportion of small distal radial artery (<2.3mm)

    Measured: Through ultrasonographic evaluation (within 1 hour)

  4. Predictor for small distal radial artery

    Clinical predictor associated with small distal radial artery

    Measured: Through ultrasonographic evaluation (within 1 hour)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2020
  2. Study start7 Jul 2017
  3. Primary completion13 Apr 2018
  4. Study completion29 Feb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
1,162 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04303923
Sponsor's protocol ID
DRAUS
Status last verified
Mar 2020
First submitted
9 Mar 2020
Last updated
12 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Radial Artery, run by Wonju Severance Christian Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The diameter of distal radial artery (time frame: Through ultrasonographic evaluation (within 1 hour)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in